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Altered expression of genes for Kir ion channels in dilated
cardiomyopathy1
Viktoria Szuts, Dalma Ménesi, Zoltán Varga-Orvos, Ágnes Zvara, Nazanin Houshmand, Miklós Bitay, Gábor Bogáts, László Virág, István Baczkó,
Balázs Szalontai, Amir Geramipoor, Diego Cotella, Erich Wettwer, Ursula Ravens, Ferenc Deák, László G. Puskás, Julius Gy. Papp, Ibolya Kiss,
András Varró, and Norbert Jost
Abstract: Dilated cardiomyopathy (DCM) is a multifactorial disease characterized by left ventricular dilation that is associated
with systolic dysfunction and increased action potential duration. The Kir2.x K+ channels (encoded by KCNJ genes) regulate the
inward rectiﬁer current (IK1) contributing to the ﬁnal repolarization in cardiac muscle. Here, we describe the transitions in the
gene expression proﬁles of 4 KCNJ genes from healthy or dilated cardiomyopathic human hearts. In the healthy adult ventricles,
KCNJ2, KCNJ12, and KCNJ4 (Kir2.1–2.3, respectively) genes were expressed at high levels, while expression of the KCNJ14 (Kir2.4)
gene was low. In DCM ventricles, the levels of Kir2.1 and Kir2.3 were upregulated, but those of Kir2.2 channels were downregu-
lated. Additionally, the expression of the DLG1 gene coding for the synapse-associated protein 97 (SAP97) anchoring molecule
exhibited a 2-fold decline with increasing age in normal hearts, and it was robustly downregulated in young DCMpatients. These
adaptations could offer a new aspect for the explanation of the generally observed physiological andmolecular alterations found
in DCM.
Key words: inward rectiﬁer potassium channels, IK1, dilated cardiomyopathy, Kir2.x, SAP97.
Résumé : La cardiomyopathie dilatée (CMD) est une maladie multifactorielle caractérisée par une dilatation du ventricule
gauche associée a` une dysfonction systolique et a` une augmentation de la durée du potentiel d'action. Les canaux potassiques
Kir2.x (codés par les gènes KCNJ) régulent le courant rectiﬁant entrant (IKI), contribuant a` la repolarisation ﬁnale du muscle
cardiaque. Nous décrivons ici la transition des proﬁls d'expression génique de quatre KCNJ a` partir du cœur d'individus normaux
vers des cœurs cardiomyopathiques dilatés. Les gènes KCNJ2, KCNJ12 et KCNJ4 (Kir2.1–2.3) étaient exprimés a` des niveaux élevés
dans les cœurs non malades, alors que l'expression du gène KCNJ14 (Kir2.4) était faible. Les niveaux de Kir2.1 et Kir2.3 étaient
régulés a` la hausse dans la CMD mais ceux des canaux Kir2.2 étaient diminués. De plus, l'expression du gène DLG1 qui code la
protéine associée au synapse SAP97, une protéine d'ancrage, était diminuée de 2 fois en fonction de l'augmentation de l'âge des
individus dont le cœur est normal, et elle était fortement diminuée chez les jeunes patients atteints de CMD. Ces adaptations
pourraient offrir un constituer une nouvelle façon d'expliquer les modiﬁcations physiologiques et moléculaires généralement
observées dans la CMD. [Traduit par la Rédaction]
Mots-clés : canaux potassiques rectiﬁants entrants, IKI, cardiomyopathie dilatée, Kir2.x, SAP97.
Introduction
Dilated cardiomyopathy (DCM) is a myocardial disorder charac-
terized by left ventricular dilation and systolic dysfunction often
leading to progressive heart failure, arrhythmias, and premature
death (Csanády et al. 1991; Jefferies and Towbin 2010). DCM is
associatedwith increased action potential duration and decreased
resting membrane potential, and the whole-cell current slope
conductance in cells of DCM is smaller than that for donor or
ischemic cardiomyopathy (Koumi et al. 1995). As a chronic multi-
factorial disease, DCM is likely to affect multiple clusters of genes.
Marked alterations were observed in the characteristics of the
inward rectiﬁer potassium current (IK1), but not in the sodium
current (INa) in ventricular myocytes of DCM patients compared
with healthy donors (Koumi et al. 1995). The IK1 current plays a
major role in maintaining the cellular resting membrane poten-
tial, and it is involved in the consequences of DCM such as the
arrhythmogenesis of coronary artery disease and ventricular ar-
rhythmias with sudden cardiac death (Csanády et al. 1991; Hibino
et al. 2010). However, themolecularmechanisms underlying these
alterations of IK1 are still largely unknown.
The IK1 current is conducted via ion channels consisting of
heteromeric assemblies of Kir2.1, Kir2.2, and Kir2.3 -subunits
(Marban 2002; Rook 2007). To shedmore light on the contribution
of -, -, and auxiliary subunits of Kir channels to the patho-
mechanism of DCM, we studied the alterations in gene expression
at the RNA and protein level in DCM diseased hearts compared
with healthy controls.
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IK1 can strongly inﬂuence the ﬁnal repolarization in cardiac
muscle (Munˇoz et al. 2007). It also regulates diastolic membrane
conductance (Rook 2007). The current is active during the action
potential (AP), but the molecular basis is poorly characterized. IK1
is underlain mostly by Kir2.x (Kir2.1, Kir2.2, and Kir2.3) ion chan-
nels (Karle et al. 2002; Marban 2002; Rook 2007). Earlier, the asym-
metrical distribution and apico-basal inhomogeneity of Kir ion
channels were investigated by Szabó et al. (2005) and Szentadrassy
et al. (2005). They found that there are no transmural differences,
at the protein level, in Kir2.1 channels in human and dog
ventricles.
The expression and properties of the abovementioned K+ chan-
nels are altered in cardiac diseases (i.e., Andersen's syndrome,
cardiac arrhythmia, long QT syndromes, hypertrophic cardiomy-
opathy, and heart failure) (Marban 2002; Gaborit et al. 2009).
Kir-type ion channels share structural similarities (Anumonwo
and Lopatin 2010) and have a role in awide variety of physiological
functions including insulin release, vascular tone, heart rate, buff-
ering of potassium, and renal salt ﬂow (Kubo et al 2005; Gaborit
et al. 2009). These ion channels strongly modulate cell excitability
and repolarization of AP, and determine the cellular restingmem-
brane potential (Munˇoz et al. 2007; Anumonwo and Lopatin 2010).
Kir2.x subunits (Kir2.1, Kir2.2, Kir2.3, and Kir2.4), encoded by the
KCNJ2, KCNJ12, KCNJ4, and KCNJ14 genes, respectively, assemble to
formhomo- or hetero-tetrameric inward rectiﬁer potassium chan-
nels in cardiomyocytes. These channels are essential for genera-
tion of the IK1 current, which is tightly but differentially regulated
within the diverse regions of the heart. The expression pattern of
translated Kir2.x channel isoforms may determine the properties
of both inward and outward components of IK1 (Warren et al.
2003).
The physiological functions of ion channels are strongly inﬂu-
enced by intracellular scaffolding, trafﬁcking, and regulatory pro-
teins. It has recently been demonstrated that the Kir2.1, Kir2.2,
and Kir2.3 isoforms colocalize with membrane-associated gua-
nylate kinase (MAGUK) proteins such as synapse-associated pro-
tein 97 (SAP97) and postsynaptic density protein 95 (PSD-95) in
cardiac muscle (Leonoudakis et al. 2000, 2004). Evidence has accu-
mulated indicating that the Kir2.x isoforms interact with protein
complexes that may be important to target and trafﬁc ion chan-
nels and anchor and stabilize the channels in the plasma mem-
brane (Vaidyanathan et al. 2010). The altered function found in
DCM patients may lead to severe heart diseases, even sudden
death.
To shed more light on the molecular basis of DCM, here we
addressed the disease-related alterations in the expression of
potassium channels and the related genes. Using quantitative
real-time reverse transcriptase PCR (qRT-PCR) and Western blot
analysis, we found characteristic differences between DCM pa-
tients and healthy controls, respectively, in the steady-state
mRNA and protein levels for pore forming -, -, and auxiliary
subunits of IK1 channels and their interacting partners. As a novel
ﬁnding, we observed age-dependent expression of the DLG1 gene
coding for SAP97 in healthy donor hearts and its robust down-
regulation in DCM. Furthermore, the subcellular distribution of
Kir2.x–SAP97 complexes was also altered in the DCM ventricle.
Our data suggest that the SAP97-regulated assembly of Kir2.x
channels markedly contributes to IK1, and that this assembly can
be altered in diseased states such as DCM.
Materials and methods
Human patients
Hearts were obtained from organ donors whose hearts were
explanted to obtain pulmonary and aortic homografts for valve
surgery. Before cardiac explantation, organ donors (n = 31) did not
receive medication apart from dobutamine, furosemide, and
plasma expanders. The investigations conform to the principles of
the Declaration of Helsinki. Experimental protocols were approved
by the University of Szeged and National Scientiﬁc and Research
Ethical Review Boards (No. 51-57/1997 OEj and 4991-0/2010-1018EKU
(339/PI/010.)). Before explantation, each heart was perfused with
cardioplegic solution (University of Debrecen, Medical and Health
Science Center, Hungary) and kept cold (4–6 °C) for 2–4 h prior to
dissection (Gaborit et al. 2009). Failing heart tissues were obtained
from patients with diagnosed DCM who underwent heart trans-
plantation and had end-stage heart failure (class III or IV heart
failure according to the New York Heart Association). The DCM
patients were 4 females and 13 males aged between 13–55 years
(average 41.53 ± 14.50 years). The clinical treatment of patients
whose heart tissues were studied is described in the Supplemen-
tary data,2 Table S1. Left ventricular biopsy sampleswere dissected
from the free wall of healthy donor hearts and patients with DCM,
and represented the epi-, mid-, and endocardial layers.
Whole-cell patch-clamp technique and electrophysiological
recordings
Cardiomyocytes were isolated from left ventricular tissues
(31 healthy donors and 4 failing) by enzymatic dissociation, as
previously described (Virág et al. 2002; Jost et al. 2009). HEPES-
buffered Tyrode's solution (composition in mmol/L: 144 NaCl,
0.33 NaH2PO4, 4.0 KCl, 1.8 CaCl2, 0.53 MgCl2, 5.5 glucose, and
5.0 HEPES, pH 7.4) served as the normal superfusate. For measur-
ing potassium currents, electrodes were ﬁlled with a solution
containing (in mmol/L) 100 K-aspartate, 45 KCl, 10 EGTA, 5 K2ATP,
5 HEPES, and 1 MgCl2, pH adjusted to 7.2 with KOH (Jost et al.
2009). All reagents were purchased from Sigma–Aldrich, St. Louis,
Missouri, USA.
Membrane currents were recorded with Axopatch-1D and
Axopatch-200B ampliﬁers (Molecular Devices Inc., Sunnyvale,
California, USA) using the whole-cell conﬁguration of the patch-
clamp technique. The cell capacitance was calculated by integrat-
ing the area under an uncompensated capacity transient, elicited
by a 10 mV hyperpolarizing pulse from –10 mV, while the holding
potential was –90 mV. Membrane currents were digitized using a
333 kHz analogue-to-digital converter (Digidata 1200 and 1320,
Molecular Devices, Inc.) under software control (pClamp 6.0 and
pClamp 8.0, Molecular Devices, Inc.). Analysis was performed us-
ing pClamp 6.0 and pClamp 8.0 software after low-pass ﬁltering at
1 kHz. All experimental data were collected at 37 °C.
All data are presented as the mean ± SEM. Statistical analysis
was performed using Student's paired and unpaired t tests. Values
for p < 0.05 were considered statistically signiﬁcant.
qRT–PCR
RNA samples were isolated using the RNeasy Fibrous Tissue kit
(Qiagen). Total RNA concentration and quality were determined
using a NanoDrop ND-1000 spectrophotometer, and the integrity
of all total RNA samples was conﬁrmed by measuring 18S rRNA
content. For in vitro reverse transcription, 2 g of total RNA was
reverse transcribed using the Stratagene Reverse Transcriptase kit
(Invitrogene, BioMedica Hungarian Ltd., Hungary) following the
manufacturer's instruction manual (25 °C for 10 min, 37 °C for
120 min, 85 °C for 5 min, and kept at 4 °C) (Zvara et al. 2005).
Each RNA sample was tested for the presence of genomic DNA
contamination. Gene-speciﬁc primers were designed using Primer
Express software (PE Applied Biosystems, Life Technologies) ac-
cording to the software guidelines. These primers (listed in the
Supplementary data,2 Table S2) were purchased from Avidin Ltd.
(Szeged, Hungary). Quantitative reverse transcription PCR was
2Supplementary data are available with the article through the journal Web site at http://nrcresearchpress.com/doi/suppl/doi/10.1139/cjpp-2012-0413.
Szuts et al. 649
Published by NRC Research Press
Ca
n.
 J.
 P
hy
sio
l. 
Ph
ar
m
ac
ol
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.n
rc
re
se
ar
ch
pr
es
s.c
om
 b
y 
CS
P 
St
af
f o
n 
08
/0
6/
13
Fo
r p
er
so
na
l u
se
 o
nl
y.
 
carried out using the Brillant II SYBRGreen QPCR master mix kit
(Stratagene, Agilent Technologies) following the manufacturer's
instruction manual. PCR reactions were then performed ﬁrst on
the Open Array platform (OpenArray system formerly Biotrove,
now Applied Biosystems, Life Technologies; 12 healthy (control)
and 12 diseased (DCM)) and then validated with the Rotor Gene
3000 (Corbett Research, Australia; 31 control and 17 DCM pa-
tients).
Speciﬁc primers, selected for their cardiac expression, were de-
signed for the following Kir ion channel coding genes: Kir2.1,
Kir2.2, Kir2.3, Kir2.4 (KCNJ2, KCNJ12, KCNJ4, and KCNJ14), Kir3.1,
Kir3.4, Kir6.1, and Kir 6.2 (as listed in the Supplementary data,2
Table S3); SUR1, SUR2 (KCNJ3, KCNJ5, KCNJ8, KCNJ9 and ABCC8,
ABCC9); K+ channel - and -subunits; SAP97 (DLG1); 8 marker
genes for ubiquitin carboxyl-terminal esterase L1 (ubiquitin
thiolesterase, UCHL1) and interleukin-6 (Barrans et al. 2002;
Borlak and Thum 2003; Gaborit et al. 2007, 2009; Soltysinska et al.
2009); 3 hypertrophy as well as end-stage markers for atrial natri-
uretic peptide precursor, brain natriuretic peptide precursors,
and -myosin heavy chain; and 4 reference genes for normaliza-
tion ((i) hypoxanthine–guanine phosphoribosyltransferase (HPRT),
(ii) glycerol-6-phosphate dehydrogenase (GAPDH), (iii) S18, and
(iv) -actin (ACTB)).
All data were collected with instrument spectral compensation
with Rotor Gene 3000 SDS 2.1 software and analyzed with the
threshold cycle (CT) relative-quantiﬁcation method (Livak and
Schmittgen 2001). The most uniformly distributed genes, HPRT
and GAPDH, were selected for data normalization (for comparison
with the literature). The relative expression of each gene versus
HPRT and (or) GAPDH was calculated for each sample (CT indi-
cates normalized data).
Data were analyzed in 2 independent ways: (i) Open Array soft-
ware was applied to the gene expression proﬁle; (ii) then Kir2.x
and SAP97 mRNA levels were validated with qRT–PCR using the
Rotor Gene 3000 version 6.0 software. For each compartment, the
relative expression of each gene versus HPRT ( 2CT values) and
(or) GAPDH were calculated. Throughout the paper, values are
presented as the mean ± SEM. Data for the healthy hearts com-
pared with the DCM samples were calculated by the Pfafﬂ
method, as previously described (Pfafﬂ 2001; Zvara et al. 2005).
Pair-wise comparisons between cardiac compartments were con-
ducted on within-patient matched samples by Student's paired t
tests (p < 0.05 considered signiﬁcant, n = 12–17). Unpaired t tests
were used for unmatched samples. The repeated measurements
were analyzed by ANOVA followed by Bonferroni's multiple com-
parison post-hoc tests.
Western blot analysis
Membrane proteins were extracted from the ventricle of hu-
man healthy donor or DCM hearts using lysis buffer. Aliquots of
equal protein content were separated using 8% SDS–PAGE and
transferred to polyvinylidene diﬂuoride ﬁlters (EMD Millipore) at
280mA for 2.5 h at 4 °C to evaluate immunoreactivity. Membranes
were blocked to prevent nonspeciﬁc binding. All materials were
purchased from Sigma–Aldrich. The ﬁlters were incubated over-
night at 4 °C with primary antibodies in Tris buffer supplemented
with Tween-20. The antibodies used were as follows: anti-Kir2.1,
anti-Kir2.2, anti-Kir2.3 (diluted 1:100; all from Alomone, Jerusalem),
anti-Kir2.4 (diluted 1:100; SantaCruz), anti-SAP97 (diluted 1:300;
LifeSpan, Bioscience Ltd., Hungary), anti--actin (diluted 1:500;
Dako Corporation), and anti-GAPDH (diluted 1:5000; Sigma–
Aldrich). Filters were then washed and incubated with horseradish-
peroxidase-conjugated IgG (DakoCorporation,AgilentTechnologies, or
Sigma–Aldrich) speciﬁc to the source of the primary antibody.
The immune complexes were detected using the ECL Western
blotting detection system (Amersham Pharmacia Biotech, UK)
following the manufacturer's instructions. The membranes,
stripped at 60 °C for 30 min in stripping buffer (100 mmol/L
2-mercapto-ethanol and 62.5 mmol/L Tris–HCl, pH 7.6), were
reprobed with anti-GAPDH and (or) anti--actin antibody to
normalize for loading differences.
Data analysis of bands
X-ray ﬁlms (Kodak) were scanned and evaluated with Image J
software verision 1.32 (NIH, www.nih.gov). The densities of spe-
ciﬁc bands were measured and corrected for the densities of
GAPDH on the same membrane. Corrected optical densities were
calculated and the differences between healthy and DCM samples
were evaluated using ANOVA and Student's t test. Data are repre-
sented as the mean ± SEM.
Immunoﬂuorescence
Cryostat sections (10 m) of healthy and DCM heart ventricle
biopsies were treated with 0.5% collagenase, blocked with 2% BSA
in calcium-free PBS, and incubated for 2 h at room temperature
with rabbit anti-Kir2.x (diluted 1:100; Alomone and Sigma–Aldrich)
and mouse anti-SAP97 antibodies (diluted 1:300; LifeSpan, BioMedica,
Ltd.). Sections were then washed and incubated with Alexa
488-labelled anti-rabbit IgG (diluted 1:400; Molecular Probes)
plus Cy3-conjugated anti-mouse IgG (diluted 1:400; Jackson
ImmunoResearch Laboratories, Inc.) for 1 h at room tempera-
ture. Nuclei were stained with 1 g/mL Hoechst 33258 in PBS for
10 min (method was modiﬁed after Piecha et al. (1999)). After
rinsing, the sections were mounted with ﬂuorescent mounting
medium (Dako Corporation, Agilent Tech.) and then viewed
and photographed using a Nikon Eclipse E600 epiﬂuorescence mi-
croscope equipped with a Spot RT Slider camera, or using an Olym-
pus Fluoview FV1000 confocal laser scanning microscope (Olympus
Life Science Europa GmbH, Hamburg, Germany). Each specimen
(n = 2–3 for each anti-Kir2.x antibody staining), was magniﬁed
20×–80× and the ﬁeld images were selected from the free wall of
ventricles to represent the variability in Kir2.x expression.
Results
Testing DCM samples for characteristic marker gene
expression
To conﬁrm the diseased status, several marker genes known to
be associated with heart disease were selected and the relative
mRNA levels were checked in the left ventricle of the DCM hearts.
As in previous reports (Barrans et al. 2002; Borlak and Thum 2003;
Gaborit et al. 2007, 2009; Soltysinska et al. 2009), steady-state
mRNA levels for atrial natriuretic peptide precursors (NPPA)
and brain natriuretic peptide precursors (NPPB) were increased
>5-fold and 3.5-fold, respectively, in DCM patients relative to the
controls (Fig. 1a). A signiﬁcant increase was also found for ubiqui-
tin carboxyl-terminal esterase L1 (ubiquitin thiolesterase, UCHL1)
(Fig. 1b), whereas mRNA levels for -myosin heavy chain did not
change signiﬁcantly in the left ventricle of DCM hearts compared
with the healthy hearts. As expected, relative mRNA levels for
interleukin-6 and -actin were signiﬁcantly lower in DCM pa-
tients than in controls.
To bridge over the differences in previous studies (Barrans et al.
2002; Borlak and Thum 2003; Soltysinska et al. 2009), we were
interested in inspecting the molecular basis of the IK1 current in
DCM.
Disease-related changes in mRNA and protein levels of
Kir2.x isoforms
Cardiac left ventricular sampleswere obtained from 12 hearts of
DCM patients and compared with those of 12 healthy donors. As a
ﬁrst step, we determined the relative mRNA levels for K+ ion
channel -subunits Kir2.1, Kir3.1, Kir3.4, Kir6.1, and Kir 6.2 as well
as for -subunits SUR1 and SUR2 by a high-throughput technique
using the Open Array platform (designed in our laboratory). We
observed marked changes in the relative mRNA levels of IK1-
related genes in the ventricle of DCM patients compared with
650 Can. J. Physiol. Pharmacol. Vol. 91, 2013
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controls (Fig. 1c). Thus, Kir2.1 and SUR1 mRNA levels increased,
while those for the Kir6.1 -subunit and SUR2 -subunit were
decreased relative to healthy controls. The relativemRNA level for
Kir3.4 was also reduced in DCM patients, whereas the mRNA lev-
els of Kir3.1 and Kir6.2 did not differ between the hearts of control
and DCM patients (Fig. 1c).
Following nanomole scale qRT–PCR screening of Kir2.x iso-
forms, the most important differences in gene expression were
veriﬁed by a conventional qRT–PCR assay, using a different set of
primers. The sample sources were extended to left ventricles of
17 DCM patients and 15 healthy donors. We also investigated the
protein levels using immunoblotting and immunoﬂuorescence
methods.
As Kir2.1, Kir2.2, and Kir2.3 are known to contribute markedly
to the repolarization phase of APs in cardiomyocytes, we validated
the alterations in the steady-state levels of mRNAs encoding these
K+ channel subunits in the heart of DCM patients. The data were
normalized to both HPRT and GAPDH mRNA levels and showed
similar differences between DCM and control heart samples
(Figs. 2a and 2b). Since mRNA levels for Kir channel subunits were
commensurable with HPRT transcripts, but did not reach 1% of
GAPDH mRNA levels, only mRNA levels relative to those of HPRT
are presented in the rest of the paper. Extended analysis con-
ﬁrmed that both Kir2.1 and Kir2.3 mRNA levels were signiﬁcantly
elevated in DCM hearts compared with the controls (Figs. 2a
and 2b). The Kir2.4 mRNA level also increased in diseased ventri-
cles. In contrast, the Kir2.2 transcript was signiﬁcantly downregu-
lated in DCM.
Next, we performed immunoblotting analysis of protein sam-
ples matching the RNA sources to reveal whether differences in
steady-state mRNA levels were manifested in protein content. As
expected, anti-human Kir2.1, Kir2.2, and Kir2.3 antibodies recog-
nized bands of 55, 45, and 57 kDa, respectively (Fig. 3a). Kir2.1
protein expression was increased in the ventricles of DCM hearts
thus conﬁrming the mRNA data. Immunoblots were reprobed
with anti-GAPDH and (or) -actin antiserum, and the intensity of
immunosignals was then quantiﬁed by image analysis software
relative to GAPDHor -actin internal controls (Figs. 3b and 3c). The
normalized protein amount of the Kir2.1 isoform was higher (by
70%) showing some individual variability, while the Kir2.2 iso-
form was lower (by 29%) in DCM compared with control hearts.
The Kir2.3 protein content, however, did not differ considerably
between donor and DCM ventricular tissue samples.
Thus, qRT–PCR analysis conﬁrmed that mRNA expression for
Kir2.1 (KCNJ2), Kir2.3 (KCNJ4), and Kir2.4 (KCNJ14) coding genes
signiﬁcantly increased (2.26-, 1.94-, and 1.6-fold, respectively),
while the mRNA level for Kir2.2 (KCNJ12) was reduced to 66% in
DCM ventricles compared with the controls. In agreement with
the RNA data, Western blot analysis revealed increased Kir2.1 and
decreased Kir2.2 protein levels in DCM patients, but the Kir2.3
level was not markedly altered compared with the controls.
Fig. 1. Marker gene expression in the left ventricle of dilated cardiomyopathic (DCM) hearts. Relative mRNA levels for the indicated markers
were determined by qRT-PCR in the left ventricle of DCM hearts and compared with those in healthy hearts. (a) Relative mRNA levels for
atrial natriuretic peptide precursors (ANPP) and brain natriuretic peptide precursors (BNPP) were increased >5-fold and 3.5-fold (p ≤ 0.01),
respectively, while -actin was decreased in DCM samples (p < 0.05). MHC, -myosin heavy chain. (b) Interleukin-6 (IL-6) and ubiquitin
carboxyl-terminal esterase L1 (UCHL-1) expression were signiﬁcantly (p ≤ 0.01) lower and higher, respectively, in DCM ventricles compared
with control hearts. (c) The mRNA expression pattern of IK1-related genes for Kir channel -subunits and associated subunits. Bars, calculated
as relative mRNA of Kir channels versus hypoxanthine-guanine phosphoribosyltransferase (HPRT), show the mean ± SE of 3 independent
experiments conducted in duplicate.
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Age-dependent and DCM-related changes in SAP97 mRNA
expression
Considering that SAP97 can associate with Kir2.2 and Kir2.3
isoforms in the heart samples (Leonoudakis et al. 2000, 2004), and
that we observed signiﬁcant changes in Kir2.1 and Kir2.2 mRNA
and protein levels, it was interesting to check whether the mRNA
level for the SAP97 regulatory protein also changed in DCM. Both
the Open Array approach and the classical qRT–PCR study on a
larger set of samples indicated downregulation of SAP97 mRNA
expression in DCM samples (not shown). Using the Open Array
system, we measured a 27% decrease in SAP97 mRNA levels in
ventricular samples of DCM patients relative to donors, similar to
the decreased Kir2.2 mRNA expression. Then we validated the
differences in the relative SAP97 mRNA levels in 31 control and
17 DCM samples using a different primer set (as listed in the
Supplementary data,2 Tables S2 and S3). SAP97 mRNA expression
was reduced by 34% in DCM compared with that in healthy hearts
(Fig. 2c; n = 31 (control) and n = 17 (DCM), p < 0.05).
Gene expression for SAP97 was validated by qRT–PCR. The
SAP97 mRNA level decreased signiﬁcantly in DCM patients using
the Open Array method (n = 12 (control) and n = 12 (DCM)) and
qRT–PCR. Furthermore, we observed robust age-dependent
changes in SAP97 mRNA expression even in donor hearts when
we compared 31 healthy and 17 DCM samples (Figs. 2c and 2d). The
SAP97 mRNA level decreased approximately 50% at an age of
40 years and higher. SAP97 mRNA levels were high at ages be-
tween 12–40 years in control cardiac ventricles and decreased by
52% in DCM patients. After 40 years of age, however, the differ-
ences in the SAP97 mRNA levels diminished between the control
and DCM hearts.
Kir2.x and SAP97 colocalize in both control and DCM
human ventricles
Based on the robust changes in Kir2.x and SAP97 mRNA expres-
sion in DCM versus normal hearts, we hypothesized that SAP97
binding to Kir2x isoforms and the distribution of their complexes
might have changed in cardiomyocytes of DCM hearts. We used
indirect immunoﬂuorescence to address the potential differences
in the distribution of SAP97–Kir2.x complexes in DCM. Using
isoform-speciﬁc antibodies, we detected Kir2.1, Kir2.2, Kir2.3, and
SAP97 in the sarcolemma. Lining up with qRT–PCR and immuno-
blot data (Figs. 2 and 3), immunoﬂuorescent visualization of Kir2.1
clearly showedmore intense immunostaining inDCMhearts than
in the control cryosections (Supplementary data,2 Fig. S1). On the
other hand, Kir2.2 and SAP97 clearly exhibited less intense immu-
noﬂuorescence in DCM compared with the healthy heart ventric-
ular sections (Figs. 4a and 4b).
Double immunoﬂuorescence showed the colocalization of SAP97
with Kir2.1 or Kir2.2 isoforms in cardiomyocytes of ventricular
tissues in both control and DCMhearts. Although the distribution
Fig. 2. Relative mRNA levels for Kir2.x isoforms and synapse-associated protein 97 (SAP97) validated by qRT–PCR. (a) mRNA analysis
conﬁrmed that both Kir2.1 and Kir2.3 mRNA levels were signiﬁcantly elevated in dilated cardiomyopathic (DCM) hearts compared with
controls. Values of mRNA for Kir2.1–Kir2.4 were normalized to hypoxanthine-guanine phosphoribosyltransferase (HPRT). (b) mRNA levels for
Kir2.x isoforms relative to those of GAPDH were measured by −CT values. (c) Gene expression for SAP97 in the human left ventricle of
healthy and DCM patients (nCONT = 31 and nDCM = 17). *, p < 0.05 compared with the control. (d) Age-dependent expression of SAP97 mRNA in
donor and DCM hearts (nCONT = 31 and nDCM = 17); *, p < 0.05; NS, no signiﬁcant difference. Values are expressed as the mean ± SEM.
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of Kir2.1 and SAP97 partially overlapped in the intercalated discs
of control sections, their colocalization was more obvious in fail-
ing human ventricles, as judged by the number and intensity of
merged yellow spots (Supplementary data,2 Fig. S1). Kir2.2 also
colocalized at the optical level of confocal microscopy with SAP97
in both control and failing samples, but the expression pattern
was different in healthy and DCM heart sections (Figs. 4a and 4b).
The differences in the distribution of merged Kir2.x and SAP97
yellow spots in the diseased tissue section suggest that the intra-
cellular structures may be disorganized or disrupted in cardiomy-
ocytes of DCM patients.
We concluded that the altered distribution of Kir2.x and SAP97
complexes revealed by immunoﬂuorescencemay be due to changes
in assembly of Kir2.x heteromers at the plasmamembrane of DCM
cardiomyocytes.
Altered inward rectiﬁer current density in the heart of DCM
patients
During the last decade a few publications have concluded from
the altered AP shape in DCM that the properties of the IK1 current
could be changed (Koumi et al. 1995). Therefore, we studied the IK1
current in human cardiomyocytes derived from the heart of
healthy donors and DCM patients. We measured IK1 by the whole-
cell patch-clamp technique in isolated ventricular myocytes, as
shown in Fig. 5.
The IK1 current was recorded by applying 300 ms long depolar-
izing voltage pulses in the voltage range of –140 to 0 mV with 3 s
pulse intervals from the holding potential of –90 mV. IK1 was
measured as the steady-state current at the end of the test pulse.
Representative current traces and the density of IK1 in ventricular
myocytes obtained from healthy (n = 31) and DCM diseased hearts
(representative cells n = 4) are shown in Figs. 5a and 5b. The dis-
eased data are from 2 representative families.
At –60 mV, IK1 density was moderately lower in the healthy
donor cardiomyocytes than in DCM human ventricular myocytes
(Fig. 5a and 5b). Steady-state inward IK1 density (Fig. 5c) was re-
duced in cells isolated from DCM ventricles compared with
healthymyocardium. Contrary to the inward component, the out-
ward component increased in the myocytes of diseased hearts,
although these data did not reach the level of statistical signiﬁ-
cance. However, we must emphasize as a limitation of our
study the small number of examined myocytes from diseased
hearts (n = 4). Data are the mean ± SEM. The tendency of the
outward component of IK1 to be increased (Fig. 5d) supports the
hypothesis that the expression pattern of Kir2.x isoforms
might have changed in the plasma membrane of the diseased
cardiomyocytes. The altered heteromeric association of these
Kir2.x channels between healthy and DCM cardiomyocytes may
explain the increased outward component.
Discussion
To address the role of potassium channels in the pathomecha-
nism of DCM, we compared the expression pattern of genes en-
coding the 1-pore Kir2.x channels in DCM and donor hearts, and
levels of the associated protein SAP97 were measured. For this
purpose, cardiac left ventricular tissue samples were obtained
from patients with DCM (n = 17) and from healthy donors (n = 31).
Our major ﬁndings were the following: (i) we observed increased
expression of Kir2.1 mRNA and protein and Kir2.3 mRNA, as op-
posed to signiﬁcantly decreased levels of Kir2.2 and SAP97 mRNA
and proteins in DCM patients compared with healthy control
Fig. 3. Differentially altered expression of Kir2.x isoforms in dilated cardiomyopathy (DCM). (a) Representative immunoblots of membrane
proteins extracted from ventricles of 2 healthy control and 6 DCM patients. (b) Immunoblots were subjected to densitometry for semiquantitative
determination of relative expression levels of Kir2.x isoforms normalized to GAPDH levels. (c) Kir2.x isoforms from Western blot analysis
normalized to -actin levels. Values are expressed as the mean ± SEM (nCONT = 10 and nDCM = 10); *, p < 0.05.
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samples; (ii) immunoﬂuorescence revealed changes in the tissue
distribution of Kir2.x subunits and in their co-localization with
SAP97; and (iii) we showed for the ﬁrst time that the gene for
SAP97 exhibits an age-dependent expression in healthy hearts,
and that other genes also have a temporally regulated expression
pattern altered in cardiomyopathy.
Comparing the relative gene expression for Kir and 2-pore ion
channels in ventricles, we observed decreased gene expression for
Kir2.2, Kir6.1, and SUR2 but, interestingly, themRNA level increased
for Kir2.1, Kir2.3, and Kir2.4 in DCM patients compared with the
healthy donors (Fig. 2). Other authors have shown similar de-
creases in DCM for Kir6.1, which is known to be involved in the
maintenance of vascular tone of microvessels (Borlak and Thum
2003; Soltysinska et al. 2009). However, in this study we have
focused especially on the investigation of the gene expression
changes underlying the IK1 current. Based on our data, and con-
sidering the reported contribution of 1-pore channels to IK1 cur-
rent properties, we hypothesize that the decreased expression of
Kir2.2 and the regulatory subunit SAP97may account in large part
for the decreased IK1 current in DCM. We propose that the ob-
served Kir2.1 and Kir2.3 upregulation may serve as a compensa-
torymechanism to avoid the detrimental decrease of IK1 in cardiac
disease.
Outward components of the IK1 current is elevated in DCM
Our hypothesis is supported by the following data from the
literature. Previously, Koumi et al. (1995) reported that the IK1
current decreases in cardiomyocytes with DCM. It is known that
IK1 has an inﬂuence on the depolarization and repolarization
phases of AP. In phase 0, the Na+ current is dominant over IK1,
whereas IK1 and other voltage-gated potassium currents are dom-
inant in repolarization phases 1–4 in cardiomyocytes. In phases 0,
3, and 4, IK1 underlying by Kir2.x channels serves as a major cur-
rent. As demonstrated by Warren et al. (2003), IK1 properties are
determined mainly by rectiﬁcation and [K+]o sensitivity of the
Kir2.1 isoformwhen Kir2.x heteromeric channels are formed. Fur-
thermore, the outward components are higher in the left ventri-
cle than in the atria or right ventricle (Dhamoon and Jalife 2005).
It has also been recently shown that the IK1 current formed by
Kir2.1 channels displays strong inward rectiﬁcation, but Kir2.3 in-
ward rectiﬁcation is incomplete and negative slope-conductance is
noticeably less steep in an in vivo guinea pigmodel and in a rabbit
model (Lodge and Normandin 1997; Warren et al. 2003; Yan et al.
2005; Rose et al. 2005). Further, when Kir2.x stable transformants
were used to study the inﬂuence of homo- and heteromeric asso-
ciations on IK1 current density, it was found that among the ho-
momers, Kir2.1 produced the highest outward component, which
decreased when Kir2.1 formed heteromers with other Kir2.x sub-
units (Schram et al. 2003; Munˇoz et al. 2007). The importance of
Kir2.1 was also supported by the observation that Kir2.1−/− knock-
out mice did not exhibit measurable IK1 (Zaritsky et al. 2001).
In our study, the expression level exhibited variability for
Kir2.3, signiﬁcantly decreased for Kir2.2, but increased for Kir2.1
mRNA and protein levels in DCM patients compared with healthy
donors. These data are consistent with earlier reports on the
Fig. 4. Immunoﬂuorescence of Kir2.2 and synapse-associated protein 97 (SAP97) colocalization. (a) The Kir2.2 channel colocalizes with SAP97
anchoring protein in the intercalated discs of healthy myocytes. To label the nucleus, 4=,6-diamidino-2-phenylindole was used. (b) Cross-section of
left ventricle shows less intense ﬂuorescence in failing human ventricle compared with the control.
654 Can. J. Physiol. Pharmacol. Vol. 91, 2013
Published by NRC Research Press
Ca
n.
 J.
 P
hy
sio
l. 
Ph
ar
m
ac
ol
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.n
rc
re
se
ar
ch
pr
es
s.c
om
 b
y 
CS
P 
St
af
f o
n 
08
/0
6/
13
Fo
r p
er
so
na
l u
se
 o
nl
y.
 
increase of Kir2.1mRNA levels in end-stage heart failure of DCMor
ischemic origin compared with donors (Borlak and Thum 2003;
Soltysinska et al. 2009). Immunoﬂuorescence and Western blot
analysis also revealed decreased expression of Kir2.2 and Kir2.3,
but increased deposition for Kir2.1 in the sarcolemma from DCM
hearts (Figs. 3a–3c, 4a, and 4b). One feasible explanation for the
pathomechanism may be that the altered gene expression and
tissue distribution of Kir2.x channels contribute to the altered IK1
current in DCM cells. Thus, we hypothesize that the increased
ratio of Kir2.1 homomers or heteromers relative to all other Kir2.x
homomer and heteromer ion channels translocated to the sarco-
lemma may account, at least in part, for the increased outward
component during the progression of the disease. However, fur-
ther investigations are required to prove this hypothesis.
Kir2.2 isoform expression compared with other Kir2.x
expression in DCM
Koumi et al. (1995) detected a 50% decrease in whole-cell current
slope conductance of IK1 in ventricular myocytes of DCM patients
versus donors. The AP had a longer duration and a slow repolar-
ization phase with a low resting membrane potential. Kir2.2−/−
knockout mice displayed a 50% reduction in IK1 relative to that of
the wild-type (Zaritsky et al. 2001), indicating that, apart from
Kir2.1, Kir2.2 also highly contributes to IK1. In our study, we found
that the mRNA levels were signiﬁcantly reduced, not only for
Kir2.2 but also for SAP97 in the ventricle of DCM patients com-
pared with donors, and the same was true for the protein level of
Kir2.2. Taken together, the data suggest that the declined currents
in the plateau and terminal phase of AP could be due to the
decreased expression of these ion channels and SAP97.
Decreased SAP97 associated with Kir2.2
Ion channels are mobile molecules that can bind different reg-
ulatory factors, and their mobility can diminish with anchoring
proteins in atrial cells. MAGUK proteins such as SAP97 are known
to associate with Kir2.x isoforms in heart and brain samples
(Leonuodakis et al. 2000; Vaidyanathan et al. 2010). In line with
these reports, our immunoﬂuorescence data showed that the
Kir2.x channels colocalize with SAP97. Furthermore, we provided
evidence that human SAP97 mRNA has an age-dependent expres-
sion in donor samples. Namely, SAP97 mRNA expression in
healthy donor ventricles is 2 times higher at a younger age (be-
tween 10–40 years) than at an older age of life. This dramatic
age-dependent decline was characteristic only of the control tis-
sues and was not observed in DCM samples. In fact, samples of
both young and old DCM patients equally showed reduced mRNA
levels similar to that of old healthy donors. The largest change,
over 50% in the mRNA expression, was seen in middle-aged pa-
tients (31–50 years) versus donors. However, the difference be-
tween healthy and DCM samples disappeared above the age of
40 years.
The endogenous Kir2.x channels associate with SAP97, speciﬁ-
cally with the C-terminal amino acids, forming signalling com-
plexes (Leonuodakis et al. 2000). Kir2.1 strongly binds SAP97, and
they show colocalization near the T-tubules. In donor samples, we
also demonstrated colocalization of SAP97 with Kir2.2, while only
partial colocalization was seen with Kir2.1 and Kir2.3 (not
shown) in the plasma membrane. In agreement with the data of
Dhamoon and Jalife (2005), the immunosignal for Kir2.1 was local-
ized in the intercalated discs and the T-tubules. Kir2.2 was found
mostly in the intercalated discs and partly at the lateral side of
myocytes in the ventricle. In DCM samples, Kir2.2 decreased dra-
matically and the immunosignal for SAP97 also decreased in par-
allel. Furthermore, only partial co-localization was seen between
Kir2.2 and SAP97 in the healthy plasma membrane, which de-
creased in DCM ventricles. On the other hand, the overlap be-
tween Kir2.2 and SAP97 immunoﬂuorescence became more
obvious, suggesting a better association of the 2 subunits (com-
pare Fig. 4a and Supplementary data,2 Fig. S1). These variations of
ion channels in the cardiomyopathic heart raise the possibility
that the complexes of assembled Kir2.x components differ in stoi-
Fig. 5. Alteration of inward rectiﬁer currents (IK1) in the ventricular cardiomyocytes of dilated cardiomyopathy (DCM) patients from
representative families. Original current traces recorded from (a) healthy and (b) DCM ventricular myocytes at a test potential ranging from
–90 to 0 mV. (c) Steady-state inward IK1 current density is measured in cells isolated from DCM compared with healthy myocardium (at a test
potential from –140 to 0 mV; inset shows the applied pulse protocol). (d) The outward component of IK1 tends to increase in DCM, but the
differences from healthy controls are not statistically signiﬁcant. Data are expressed as the mean ± SEM.
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chiometry and (or) structure from those in healthy hearts. The
SAP97 and Kir ion channels may be novel target molecules in the
diagnosis and effective treatment of cardiomyopathy.
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